title: Stroke prevention in nonvalvular atrial fibrillation.
authors.affiliation: Department of Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA.
authors.forename: Leila
authors.initials: L
authors.lastname: Ganjehei
authors.forename: Ali
authors.initials: A
authors.lastname: Massumi
authors.forename: Mehdi
authors.initials: M
authors.lastname: Razavi
authors.forename: Abdi
authors.initials: A
authors.lastname: Rasekh
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D020517:Atrial Appendage / Q000601:surgery; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D001562:Benzimidazoles / Q000627:therapeutic use; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation; D006348:Cardiac Surgical Procedures / Q000009:adverse effects / Q000295:instrumentation; D000069604:Dabigatran; D006801:Humans; D011314:Preventive Health Services; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran